RVII
RVIICIK 0002131040
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (CNXC 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade RVII commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
RVII prices IPO of 8M shares at $25, raising $185.1M net for YC-focused BDC advised by Robinhood unit
5 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Nov 12, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Statements of Operations (Unaudited)
| Description | Three months ended September 30, 2026 (a) | Six months ended September 30, 2026 (a) |
|---|---|---|
| Income: | ||
| Dividend income | 901,656 | 901,656 |
| Total investment income | 901,656 | 901,656 |
| Expenses: | ||
| Organizational expenses (b) | 123,896 | 1,315,412 |
| Professional fees | 422,420 | 519,191 |
| Sub-administrator and custody expenses | 56,848 | 92,698 |
| Management fees | 555,038 | 555,038 |
| Incentive fees | 41,815 | 41,815 |
| Trustees’ fees | 65,685 | 96,622 |
| Other general and administrative expenses | 125,236 | 154,326 |
| Total expenses before cost support and reimbursement | 1,390,938 | 2,775,102 |
| Reversal of organizational costs support and reimbursement (b) | 1,603,347 | — |
| Total expenses after cost support and reimbursement | 2,994,285 | 2,775,102 |
| Net investment loss | (2,092,629) | (1,873,446) |
| Net realized gain and change in unrealized appreciation: | ||
| Net unrealized gain on investments | 209,076 | 209,076 |
| Net decrease in net assets from operations | (1,883,553) | (1,664,370) |
Statements of Assets and Liabilities
| Description | September 30, 2026 (Unaudited) | March 31, 2026 |
|---|---|---|
| Assets: | ||
| Investments at fair value (cost of $215,949,685 and $8,850,000, respectively) | 216,158,761 | 8,850,000 |
| Cash | — | 5,750,000 |
| Receivable from investments sold or redeemed | 250,000 | — |
| Dividend receivable | 557,780 | — |
| Prepaid expenses and other assets | 105,491 | — |
| Deferred offering costs | — | 259,494 |
| Total assets | 217,072,032 | 14,859,494 |
| Liabilities: | ||
| Accrued expenses | 661,007 | 19,830 |
| Accrued organizational expenses (a) | — | 411,831 |
| Accrued offering costs (Note 5) | 3,042,752 | 259,494 |
| Management fee payable | 555,038 | — |
| Accrued incentive fee | 41,815 | — |
| Due to custodian | 1,323,219 | — |
| Due to Affiliates | 314,807 | — |
| Payable for investments purchased | 700,000 | 2,100,000 |
| Total liabilities | 6,638,638 | 2,791,155 |
| Commitments and contingencies (Note 8) | ||
| Net Assets | 210,433,394 | 12,068,339 |
| Net Assets consist of: | ||
| Paid-in capital | 212,529,425 | 12,500,000 |
| Total accumulated deficit | (2,096,031) | (431,661) |
| Net Assets | 210,433,394 | 12,068,339 |
| Net asset value per share: (b) | ||
| Shares outstanding (c) | 9,066,384 | 488,290 |
| Net asset value per share | 23.21 | 24.72 |
Statement of Cash Flows (Unaudited)
| Description | Six months ended September 30, 2026 (a) |
|---|---|
| Cash flows from operating activities: | |
| Net decrease in net assets from operations | (1,664,370) |
| Adjustments to reconcile net decrease in net assets from operations to net cash used in operating activities: | |
| Purchases of investments | (29,036,627) |
| Net purchases of money market funds | (180,213,058) |
| Proceeds from investments sold or redeemed | 500,000 |
| Net change in unrealized gain on investments | (209,076) |
| Increase (decrease) in operating assets and liabilities: | |
| Dividend receivable | (557,780) |
| Accrued expenses | 641,177 |
| Due to custodian | 1,323,219 |
| Prepaid expenses and other assets | (105,491) |
| Management fee payable | 555,038 |
| Accrued incentive fee | 41,815 |
| Accrued organizational expenses | (411,831) |
| Due to Affiliates | 314,807 |
| Net cash used in operating activities | (208,822,177) |
| Cash flows from financing activities: | |
| Proceeds from issuance of shares, net of underwriting commissions | 204,245,624 |
| Offering costs paid | (1,173,447) |
| Net cash provided by financing activities | 203,072,177 |
| Net decrease in cash | (5,750,000) |
| Cash, beginning of period | 5,750,000 |
| Cash, end of period | — |
| Supplemental disclosure of cash flow information | |
| Deferred offering costs charged to paid-in-capital but unpaid at September 30, 2026 | 3,042,752 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗